| Labatec Pharma SA - Pyrazinamide Labatec 750 mg, comprimés |
| 57699 | | 03 | | Pyrazinamide Labatec 750 mg | | comprimés | | J04AK01 | | Pyrazinamide | | 17.10.2017 | | |
|
| Composition |
| pyrazinamidum 750 mg, carboxymethylamylum natricum A corresp. natrium max. 2.94 mg, cellulosum microcristallinum, copovidonum, calcii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | Active Agent | Dose |
|---|
| Pyrazinamide | 750 mg |
| | | | Inactive agents |
|---|
| Calcii Stearas | | Carboxymethylamylum Natricum A | | Cellulosum Microcristallinum | | Copovidonum | | Pro Compresso |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 100 | PR | PR | A | | Yes |
|
